SELLAS Life Sciences
44 hedge funds and large institutions have $4.27M invested in SELLAS Life Sciences in 2016 Q4 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
903% more call options, than puts
Call options by funds: $11.4M | Put options by funds: $1.14M
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.37M |
| 2 |
Millennium Management
New York
|
+$1.23M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$855K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$773K |
| 5 |
D.E. Shaw & Co
New York
|
+$715K |
Top Sellers
SLS Hedge Fund Activity: Q4 2016 in Review
44 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q4 2016, worth a combined $4.27M.
Buyers outnumbered sellers: 44 funds opened new SLS positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $1.37M.
- 44 institutional investors held SELLAS Life Sciences (SLS) as of Q4 2016, up from 0 in Q3 2016.
- Funds reported $4.27M of SELLAS Life Sciences stock for Q4 2016.
- 44 funds opened new SELLAS Life Sciences positions in Q4 2016 and 0 closed out, a net change of +44 holders.
- The largest SELLAS Life Sciences buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $1.37M added.
Based on aggregated 13F filings for Q4 2016.